German guideline diverticular disease/diverticulitis: Part I: Methods, pathogenesis, epidemiology, clinical characteristics (definitions), natural course, diagnosis and classification
- PMID: 36411504
- PMCID: PMC9731664
- DOI: 10.1002/ueg2.12309
German guideline diverticular disease/diverticulitis: Part I: Methods, pathogenesis, epidemiology, clinical characteristics (definitions), natural course, diagnosis and classification
Abstract
Diverticulosis and diverticular disease are ranked among the most common gastroenterological diseases and conditions. While for many years diverticulitis was found to be mainly an event occurring in the elder population, more recent work in epidemiology demonstrates increasing frequency in younger subjects. In addition, there is a noticeable trend towards more complicated disease. This may explain the significant increase in hospitalisations observed in recent years. It is not a surprise that the number of scientific studies addressing the clinical and socioeconomic consequences in the field is increasing. As a result, diagnosis and conservative as well as surgical management have changed in recent years. Diverticulosis, diverticular disease and diverticulitis are a complex entity and apparently an interdisciplinary challenge. To meet theses considerations the German Societies for Gastroenterology and Visceral Surgery decided to create joint guidelines addressing all aspects in a truely interdisciplinary fashion. The aim of the guideline is to summarise and to evaluate the current state of knowledge on diverticulosis and diverticular disease and to develop statements as well as recommendations to all physicians involved in the management of patients with diverticular disease.
Keywords: colon; diagnosis; diverticular disease; diverticulitis; treatment.
© 2022 The Authors. United European Gastroenterology Journal published by Wiley Periodicals LLC on behalf of United European Gastroenterology.
Conflict of interest statement
Honoraria for talks AllergoSan, Graz, Austria. Falk, Freiburg, Germany. Ferring Arzneimittel, Kiel, Germany. Nikkiso, Langenhagen, Gemany. Consultation and studies Falk Pharma, Freiburg, Germany. Ferring Arzneimittel. Kiel, Germany. No other conflict of interest.
References
-
- Lammert F, Lynen Jansen P, Lerch MM. Weissbuch Gastroenterologie 2020/2021. Berlin: DeGruyter; 2019.
-
- OCEBM Levels of Evidence Working Group* . The Oxford levels of evidence 2. Oxford Centre for Evidence‐Based Medicine. * OCEBM Levels of Evidence Working Group = Jeremy Howick, Iain Chalmers (James Lind Library), Paul Glasziou, Trish Greenhalgh, Carl Heneghan, Alessandro Liberati, Ivan Moschetti, Bob Phillips, Hazel Thornton, Olive Goddard and Mary Hodgkinson. (abgerufen am 05.03.2020). https://www.cebm.net/index.aspx?o=5653
-
- CEBM (Centre for Evidence‐Based Medicine) . Critical appraisal tools; 2017. (abgerufen am 05.03.2020). http://www.cebm.net/critical‐appraisal/
-
- Newcastle‐Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta‐analyses (2014). (abgerufen am 06.03.2020). http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
-
- Hsu CW, Wang JH, Kung YH, Chang MC. What is the predictor of surgical mortality in adult colorectal perforation? The clinical characteristics and results of a multivariate logistic regression analysis. Surg Today. 2017;47(6):683–9. 10.1007/s00595-016-1415-4 zuletzt 4 Ab hier ‐S 10‐270 wieder im Text - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
